A pilot dose finding study of pioglitazone in autistic children
Conclusions and relevancePioglitazone is well-tolerated and shows a potential signal in measures of social withdrawal, repetitive, and externalizing behaviors. Randomized controlled trials using the confirmed dose are warranted.Trial registrationClinicalTrials.gov,NCT01205282. Registration date: September 20, 2010.
Source: Molecular Autism - Category: Molecular Biology Source Type: research
More News: Actos | Autism | Children | Eyes | Molecular Biology | Obsessive Compulsive Disorder | Statistics | Study | Yale